LAB vs PHM · rev $174.4M vs P/E 7.7, rev $17.95B
Standard Biotools Inc (LAB) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
LAB currently screens at market cap $317.1M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the LAB and PHM stock pages for the full models.
Not investment advice.